Non categorizzato FDA approves Amgen’s small cell lung cancer drug Maggio 16, 2024 0 commenti The United States Food and Drug Administration (FDA) said on Thursday it granted accelerated approval to tarlatamab, Amgen’s small cell lung cancer drug, also known as Imdelltra.”This application was … About the author:
Get involved!
Comments